The exact scope and duration is clear, and one question is what will happen to release of CDC data that employers and insurers use in pricing.
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices ...
President Donald Trump’s first moves on Medicaid and the Affordable Care Act signal his administration’s willingness to make major changes to the government programs.
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...
Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The Biden Administration announced the next batch of 15 prescription drugs that will be included in price negotiations with companies — with the aim of lowering costs for people covered by Medicare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback